Publications by authors named "Christopher Gainza"

Claim this Profile
S
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes.
Elaine C Chen, Pavlo Gilchuk, Seth J Zost, Philipp A Ilinykh, Elad Binshtein, Christopher Gainza

Cell Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
Michael P Doyle, Joseph R Genualdi, Adam L Bailey, Nurgun Kose, Christopher Gainza

mBio· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer.
Naveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, Elad Binshtein, Rita E Chen, Christopher Gainza

J Clin Invest· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.
Jinhui Dong, Seth J Zost, Allison J Greaney, Tyler N Starr, Adam S Dingens, Christopher Gainza

Nat Microbiol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Lauren E Williamson, Kristen M Reeder, Kevin Bailey, Minh H Tran, Vicky Roy, Christopher Gainza

Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail.
Jinhui Dong, Seth Zost, Allison Greaney, Tyler N Starr, Adam S Dingens, Christopher Gainza

bioRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis